Ryoko Umebayashi

419 total citations
23 papers, 232 citations indexed

About

Ryoko Umebayashi is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ryoko Umebayashi has authored 23 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ryoko Umebayashi's work include Aortic aneurysm repair treatments (8 papers), Aortic Disease and Treatment Approaches (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Ryoko Umebayashi is often cited by papers focused on Aortic aneurysm repair treatments (8 papers), Aortic Disease and Treatment Approaches (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Ryoko Umebayashi collaborates with scholars based in Japan, United States and Nigeria. Ryoko Umebayashi's co-authors include Haruhito A. Uchida, Jun Wada, Hitoshi Sugiyama, Yuka Okuyama, Hidemi Takeuchi, Michihiro Okuyama, Alan Daugherty, Venkateswaran Subramanian, Ken Sugimoto and Hiromi Rakugi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Ryoko Umebayashi

20 papers receiving 230 citations

Peers

Ryoko Umebayashi
Ryoko Umebayashi
Citations per year, relative to Ryoko Umebayashi Ryoko Umebayashi (= 1×) peers Linnea Malmgren

Countries citing papers authored by Ryoko Umebayashi

Since Specialization
Citations

This map shows the geographic impact of Ryoko Umebayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Umebayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Umebayashi more than expected).

Fields of papers citing papers by Ryoko Umebayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoko Umebayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Umebayashi. The network helps show where Ryoko Umebayashi may publish in the future.

Co-authorship network of co-authors of Ryoko Umebayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoko Umebayashi. A scholar is included among the top collaborators of Ryoko Umebayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoko Umebayashi. Ryoko Umebayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uchida, Haruhito A., Keiko Tanaka, Hidemi Takeuchi, et al.. (2024). A case of renal hypouricemia due to T217M mutation in SLC22A12 incidentally associated with IgA nephropathy. SHILAP Revista de lepidopterología. 12(9). e9368–e9368.
2.
Uchida, Haruhito A., Hidemi Takeuchi, Ryoko Umebayashi, et al.. (2022). The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study. Journal of Diabetes Research. 2022. 1–12. 5 indexed citations
4.
Uchida, Haruhito A., Ryoko Umebayashi, Hidemi Takeuchi, et al.. (2022). Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Biomolecules. 12(8). 1117–1117. 8 indexed citations
5.
Umebayashi, Ryoko, et al.. (2022). Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama Prefecture. Journal of Personalized Medicine. 12(1). 97–97. 10 indexed citations
6.
Uchida, Haruhito A., Michihiro Okuyama, Hidemi Takeuchi, et al.. (2020). Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms but not Abdominal Aortic Aneurysms nor Atherosclerosis in ApoE-Deficient Mice. American Journal of Hypertension. 34(5). 467–475. 4 indexed citations
7.
Uchida, Haruhito A., Hidemi Takeuchi, Yuka Okuyama, et al.. (2019). <p>Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcome</p>. International Journal of Nephrology and Renovascular Disease. Volume 12. 143–152. 4 indexed citations
8.
Takeuchi, Hidemi, Haruhito A. Uchida, Yuka Okuyama, et al.. (2018). The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients. Aging and Disease. 9(2). 192–192. 53 indexed citations
9.
Okuyama, Yuka, Haruhito A. Uchida, Toshiyuki Iwahori, et al.. (2018). The relationship between repeated measurement of casual and 24-h urinary sodium-to-potassium ratio in patients with chronic kidney disease. Journal of Human Hypertension. 33(4). 286–297. 6 indexed citations
10.
Umebayashi, Ryoko, et al.. (2018). Cilostazol Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 38(4). 903–912. 44 indexed citations
11.
Okuyama, Michihiro, Hidemi Takeuchi, Haruhito A. Uchida, et al.. (2018). Peripheral artery disease is associated with frailty in chronic hemodialysis patients. Vascular. 26(4). 425–431. 13 indexed citations
12.
Umebayashi, Ryoko, Haruhito A. Uchida, Yuka Okuyama, et al.. (2018). The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 study. Biomarkers. 24(3). 255–261. 7 indexed citations
13.
Uchida, Haruhito A., Hidemi Takeuchi, Yuka Okuyama, et al.. (2018). Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis. Geriatrics and gerontology international. 18(12). 1597–1602. 19 indexed citations
14.
Uchida, Haruhito A., Ryoko Umebayashi, Hidemi Takeuchi, et al.. (2017). Practical efficacy of olmesartan versus azilsartan in patients with hypertension. Blood Pressure Monitoring. 22(2). 59–67. 4 indexed citations
15.
Okuyama, Michihiro, Haruhito A. Uchida, Ryoko Umebayashi, et al.. (2017). Abstract 640: Overexpression of Vasohibin-2 Exacerbates Development of Angiotensin II-Induced Thoracic Aortic Aneurysms Independent of VeEGF. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1).
16.
Terasaka, Tomohiro, Haruhito A. Uchida, Ryoko Umebayashi, et al.. (2016). The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease. BMC Nephrology. 17(1). 122–122. 17 indexed citations
17.
Takeuchi, Hidemi, Michihiro Okuyama, Haruhito A. Uchida, et al.. (2016). Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm. PLoS ONE. 11(10). e0164015–e0164015. 12 indexed citations
18.
Uchida, Haruhito A., Tomokazu Nunoue, Ryoko Umebayashi, et al.. (2014). Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome. CEN Case Reports. 4(2). 190–195. 3 indexed citations
19.
Uchida, Haruhito A., et al.. (2014). Abstract 86: Intercellular Adhesion Molecule 1 Deficiency Attenuated Angiotensin II--Induced Abdominal Aortic Aneurysms in Apolipoprotein E--Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 1 indexed citations
20.
Katsuyama, Takayuki, Haruhito A. Uchida, Yoshinobu Maeda, et al.. (2013). Large Vessel Vasculitis with Myelodysplastic Syndrome. Internal Medicine. 53(1). 63–66. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026